Related Experiment Video
Updated: Jul 10, 2026
07:01
A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)
Published on: February 7, 2025
Late consequences of chronic pediatric illness
1Childrens Hospital Los Angeles, University of Southern California Keck School of Medicine, 4650 Sunset Blvd #82, Los Angeles, CA 90027, USA.
The Psychiatric Clinics of North America
|October 17, 2007
Summary
Adapting to chronic disease presents challenges, impacting quality of life. Standardizing definitions for childhood chronic health conditions is crucial for accurate assessment and care, especially during care transitions.
Area of Science:
- Pediatric Health
- Chronic Disease Management
- Psychosocial Development
Background:
- Increased survival with chronic diseases does not guarantee improved quality of life.
- Varied definitions and measurements of chronic health conditions hinder accurate prevalence estimation and impact assessment.
- Distinguishing illness/treatment effects from psychosocial functioning issues in children is complex.
Purpose of the Study:
- To highlight challenges in chronic disease adaptation and quality of life.
- To emphasize the need for international consensus on defining childhood chronic health conditions.
- To underscore the importance of integrated mental health assessment and care transitions for chronically ill youth.
Main Methods:
- Systematic review of outcome variations.
- Analysis of challenges in attributing psychosocial issues.
- Discussion of care transition needs.
Main Results:
- Wide variation in chronic health condition prevalence estimates due to inconsistent definitions.
- Difficulty in assessing the impact of disability on children's health and social functioning.
- Need for integrated mental health care and structured transition processes.
Conclusions:
- Comprehensive care for chronically ill children must include mental health assessment and treatment.
- A standardized definition of chronic health conditions in childhood is essential.
- Ongoing evaluation and support are critical for adults with childhood chronic conditions, addressing psychosocial, educational, and vocational needs.
Related Concept Videos
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:24Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD: